Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

fore ai AG

History from 28 Apr 2023

UID
CHE-367.656.224
Legal form
AG
Canton
ZH
Founded
28 Apr 2023
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 144k
36k72k108k144k9 Mar 2026 · CHF 141k2 Jun 2026 · CHF 144k
  • shares
  • Vorzugsaktien Seed

Record

  1. SHAB published 3 May 2023 · legal date 28 Apr 2023

    Company formed

    Founded 28 Apr 2023

    SHAB HR01-1005737375 ↗

  2. SHAB published 9 Mar 2026 · legal date 27 Feb 2026

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    100’000 → 141’191
    Shares
    100’000 → 141’191
    New shares, % of post-step shares
    29.2% (41’191 new)
    Share classes
    95’800 × CHF 1 · 45’391 × CHF 1 Vorzugsaktien Seed

    Aktienkapital neu: CHF 141'191.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 141'191.00 [bisher: CHF 100'000.00]. Aktien neu: 95'800 Namenaktien zu CHF 1.00 und 45'391 Namenaktien zu CHF 1.00 (Vorzugsaktien Seed) [bisher: 100'000 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 27.02.2026 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.95 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006589758 ↗

  3. SHAB published 9 Mar 2026 · legal date 27 Feb 2026

    Capital band adopted

    SHAB HR02-1006589758 ↗

  4. SHAB published 2 Jun 2026 · legal date 27 May 2026

    Capital increase

    Capital increased · undecided

    Paid in cash

    Nominal capital
    141’191 → 144’266
    Shares
    141’191 → 144’266
    New shares, % of post-step shares
    2.1% (3’075 new)
    Share classes
    95’800 × CHF 1 · 48’466 × CHF 1 Vorzugsaktien Seed

    Aktienkapital neu: CHF 144'266.00 [bisher: CHF 141'191.00]. Liberierung Aktienkapital neu: CHF 144'266.00 [bisher: CHF 141'191.00]. Aktien neu: 95'800 Namenaktien zu CHF 1.00 und 48'466 Namenaktien zu CHF 1.00 (Vorzugsaktien Seed) [bisher: 45'391 Namenaktien zu CHF 1.00 (Vorzugsaktien Seed) und 95'800 Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.55 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006664244 ↗

Published by 8 Oct 2026